ArticleFrontiers in oncology2022

Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking.

Zhangpeng Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.